Influenza Clinical Trial
Official title:
Evaluation of a Multi-faceted Influenza Vaccination Implementation Strategy for Health Care Workers in Hospitals
Influenza is a serious disease which can cause severe illness and even death among patients.
Health care workers (HCWs) often get infected with influenza and up to 76% of them keep
working while being ill. Immunizing HCWs is therefore an essential factor in protecting
patients from influenza as HCWs easily transmit influenza to their patients.
However, despite recommendations from the Dutch Health Council since 2007, vaccine uptake
among HCWs remains low.
The aim of this study is to develop an effective implementation strategy on the basis of
previous behavioural studies and to evaluate its value in a clustered randomized trial in
all Dutch University Medical Centers (UMCs). Also, we want to assess the program elements
that are associated with a higher vaccine uptake and the cost-effectiveness of such an
implementation strategy.
The results of this study will give more insights in the way influenza vaccination campaigns
should be directed in order to achieve high vaccine uptake rates among HCWs in hospitals.
Since influenza vaccination rates among hospital HCWs are low, we developed an
implementation program which will be tested in this large target group. The primary
objective is to evaluate the short- and long-term effects of a multi-faceted implementation
program to improve influenza vaccine uptake among HCWs in hospitals over two influenza
seasons. Its clinical effects are assessed by means of a randomized controlled trial in
selected divisions (e.g. internal medicine, pediatric ward) of all six randomized UMCs in
the Netherlands. Secondary aims are to assess program elements associated with higher
vaccine uptake among the target group and to evaluate the cost-effectiveness of the program.
The program will be developed using the Intervention Mapping method taking into account all
evidence from systematic literature review and the questionnaire study among HCWs in UMCs as
part of our before measurement (2008). The Intervention Mapping method is a theoretical
framework developed in the field of health education and promotion to systematically design
theory and evidence based health promotion programs.
In 2008, we have selected five divisions of all UMCs that will take part in the trial.
Before measurement showed wide variation of uptake (<15-50%) and 11 determinants that
explained more than 95% of the vaccination behaviour. Three UMCs will adopt the intervention
developed by the research group using the Intervention Mapping method, and three UMCs will
serve as controls. The current implemented programs in the UMCs vary widely ranging from
passive information systems to involvement of the Board of Directors. Our intervention will
exist of a multi-faceted program aimed at both HCWs and management of the divisions. Our
primary outcome will be the recorded vaccine uptake among HCWs in the UMCs.
To evaluate the short-term and long-term process of the program, web-based questionnaires
will be developed and directed at all health care workers of the selected divisions in all
UMCs. The questionnaire will contain questions about vaccine uptake and HCWs' opinions on
influenza, vaccination and the vaccination campaign. Absenteeism will also be registered.
Finally, patient data will be collected in the participating divisions of all UMCs in order
to investigate if there is a relationship between vaccinating HCWs and morbidity and
mortality in patients because of influenza.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
| Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
| Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
| Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
| Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
| Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
| Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
| Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
| Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
| Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
| Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
| Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
| Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
| Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
| Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
| Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
| Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
| Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |